Brain cancer vaccine effective in some patients

Most people with the deadly brain cancer glioblastoma die less than 18 months after diagnosis. But a multicenter clinical trial of a personalized vaccine that targets the aggressive cancer has indicated improved survival rates for such patients. The study appears May 29 in the Journal of Translational Medicine.

New cohort of College Prep Scholars announced

Washington University in St. Louis has admitted 50 rising high school sophomores to its innovative College Prep Program, a multiyear initiative that prepares high-achieving students with limited financial resources for college. The students represent public, private and charter schools from across the region. They will live and study on campus for three summers,  participating in science labs, preparing their college essays and studying with top university faculty.